Seres Therapeutics (MCRB) IPO Down 17% after Friday's 180% Surge

Last week's red hot IPO for Seres Therapeutics (NASDAQ: MCRB) is under heavy pressure Monday. After pricing at $18 and closing its first day of trading up 180% to $51.40, shares are down 17.6% to $42.35 today.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
• Tesla (TSLA) erases gains, drops to $140 again